With the expansion of its Longford medical manufacturing facility, Technimark will add 80 new high-skilled jobs.
Over the next two years, as the business expands its current plant by 50,000 square feet, these positions will be filled. The €26 million investment will increase the facility’s capacity for medical manufacturing processes like contract manufacturing, precision injection moulding, and device assembly.
“A key component in our organic growth strategy is ensuring we have state-of-the-art cleanroom facilities and open capacity to support our customers’ current and future manufacturing needs,” said Kris Peavy, chief commercial officer and president of healthcare at Technimark.
“Our many expansions around the globe underpin that strategy.”
The upgraded Longford facility will also house Technimark’s first innovation hub in Europe, which will have offices for designers and engineers as well as a production lab for creating prototypes.
Process and quality engineers, tool makers, and operations staff are currently in need of employment, according to Colm Cuffe, VP of European operations at Technimark, and recruitment for the new positions will soon begin.
As the demand for medical manufacturing increases, the plastic injection moulding company is currently expanding its facilities in the US, the UK, Germany, and China.
CEO Brad Wellington said the business is “committed” to growth in Ireland. “Ireland is seeing pronounced growth in the medtech market, and our facility is ideally located to serve our customers in the region,” he said.
Taoiseach Micheál Martin, TD, was in Longford for the announcement. “This is an important day for Technimark, Longford and the wider region, and testament to the continued attractiveness of Ireland as a place where businesses of all sizes can flourish and thrive,” he said.
The investment is supported by the Irish Government through IDA Ireland.
“This investment positions this facility as a key strategic site within the Technimark Group, from which the company is expanding its healthcare manufacturing capabilities in Europe,” said IDA’s interim CEO, Mary Buckley.